Is HCYT or EQR a better dividend investment in 2026?

HCYT currently yields 201.01% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: HCYT offers higher current income.

What is the dividend yield difference between HCYT and EQR?

HCYT has a forward dividend yield of 201.01% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 195.14 percentage points.

Home › Compare › HCYT vs EQR

HCYT vs EQR: Dividend Comparison 2026

HCYT yields 201.01% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HCYT wins by $122.83M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HCYT

● Live price

201.01%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$122.88M

Annual income

$62,103,539.90

Full HCYT calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — HCYT vs EQR

📍 HCYT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HCYT	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HCYT + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HCYT pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCYT

Annual income on $10K today (after 15% tax)

$17,085.43/yr

After 10yr DRIP, annual income (after tax)

$52,788,008.92/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, HCYT beats the other by $52,783,354.65/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCYT + EQR for your $10,000?

HCYT: 50%EQR: 50%

100% EQR50/50100% HCYT

Portfolio after 10yr

$61.46M

Annual income

$31,054,507.75/yr

Blended yield

50.52%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

HCYT

No analyst data

Altman Z

-150.6

Piotroski

3/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCYT buys

EQR buys

No recent congressional trades found for HCYT or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHCYTEQR

Forward yield	201.01% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$122.88M ✓	$47.8K
Annual income after 10y	$62,103,539.90 ✓	$5,475.61
Total dividends collected	$115.84M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: HCYT vs EQR ($10,000, DRIP)

Year	HCYT Portfolio	HCYT Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$30,801	$20,100.50	$11,380	$679.82	+$19.4K → HCYT
2	$90,817	$57,860.33	$13,014	$837.25	+$77.8K → HCYT
3	$256,617	$159,443.16	$14,961	$1,036.20	+$241.7K → HCYT
4	$695,638	$421,057.46	$17,297	$1,289.22	+$678.3K → HCYT
5	$1,811,064	$1,066,731.28	$20,121	$1,613.15	+$1.79M → HCYT
6	$4,533,343	$2,595,504.46	$23,561	$2,030.84	+$4.51M → HCYT
7	$10,922,551	$6,071,874.75	$27,783	$2,573.54	+$10.89M → HCYT
8	$25,359,524	$13,672,394.20	$33,013	$3,284.39	+$25.33M → HCYT
9	$56,801,975	$29,667,284.47	$39,547	$4,223.51	+$56.76M → HCYT
10	$122,881,654	$62,103,539.90	$47,791	$5,475.61	+$122.83M → HCYT

HCYT vs EQR: Complete Analysis 2026

HCYT — Stock

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Full HCYT Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this HCYT vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCYT vs SCHD HCYT vs JEPI HCYT vs O HCYT vs KO HCYT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.